PSI is a non-profit organisation formed in 1977 which provides a forum for regular discussion of statistics and issues relating to the practice of statistics in the pharmaceutical industry, as well as promoting good statistical practice within the industry.

Why join PSI


We provide...

opportunities for our members to network, develop themselves and shape the industry

We are...

run by our membership through a network of committees and special interest groups

We promote...

best statistical practice to our members and promote the value of statistics to the external world

Statisticians in the Pharmaceutical Industry
Executive Office: Durford Mill, Petersfield, Hampshire, GU31 5AZ e: PSI@MCI-group.com t: +44 (0)1730 715 235 

Latest News


Show all news

EventsFuture Events


  • PSI Toxicology SIG Webinar - Dates: 19 – 19 Jun, 2018

    Ludwig A. Hothorn will be presenting on recent developments of statistics in toxicology - using R.
  • Small Populations and Level of Evidence - Dates: 27 – 27 Jun, 2018

    The Basel Biometric Society (BBS) and the European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) are pleased to organize a European Scientific Meeting on this relevant topic.
  • PSI One Day Meeting and Workshop: Real World Evidence: Generalisability of Treatment Comparisons for Decision Making - Dates: 18 – 18 Sep, 2018

    RWE data are an increasingly valuable resource in drug development. One area where this data is being used regularly is in the generalisability of treatment comparisons. This event will focus on this topic and more specifically on new advances in indirect comparisons, generalizability approaches for clinical trial data into the real world setting and cross-design approaches combining observational and randomized data.
  • Statistics Fundamentals of Clinical Trials for Non-Statisticians (or ‘How to speak stats in a day!’) - Dates: 20 – 20 Sep, 2018

    This is a 1-day course, aimed to introduce statistics to people who work on Clinical Trials, but who are not Statisticians. No previous knowledge of Statistics is assumed as we start right at the beginning with the basics. Many practical examples are given and the emphasis is on application and understanding rather than the equations and the technical background.
  • Regulatory Interactions for Statisticians - Dates: 26 – 27 Sep, 2018

    The course objective is to inform statisticians about the likely interactions they might have with regulatory agencies, both during a submission and at other times during drug development, and give advice on how to make these interactions most effective.
  • IDEAS Dissemination Workshop - Dates: 26 Sep, 2018

    The aim of the workshop is to translate and promote novel methodologies developed by IDEAS and is geared towards statisticians and trialists with an interest in novel methods for early phase clinical trials. Therefore, it will be of interest to those working in academia, industry, HTA or regulatory authorities.
  • Introduction To Industry Training Course 2018 - Dates: 01 Oct, 2018 – 01 Nov, 2019

    AIM: To describe the drug development process from research right through to research, toxicology, data management & role of the CRO, clinical trials, product development & manufacture and marketing.